Our Services
Medical Information
Helpful Resources
Published on: 4/13/2026
Most common Zepbound side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, decreased appetite, fatigue, and mild injection site reactions. These typically improve within the first few weeks, especially with provider-guided dose increases and simple steps like eating smaller, lower-fat meals.
Serious safety warnings include:
Because Zepbound side effects can overlap with symptoms of other conditions—and some warning signs demand immediate medical attention—it's important to understand what your body is telling you before deciding on next steps. Take a free, instant, online symptom check to get personalized insight into your symptoms and clearer guidance on what to do next.
Reviewed for medical accuracy: 07/10/2026
If you're starting Zepbound® (tirzepatide) for weight management, it's normal to have questions—especially about Zepbound side effects. Knowing what to expect can help you feel more confident and prepared.
Zepbound is an FDA-approved prescription medication for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol). It works by activating GIP and GLP-1 receptors—hormones involved in appetite control, fullness, and blood sugar regulation.
Like any medication, Zepbound can cause side effects. Most are mild to moderate and improve over time, but some can be serious. Here's what you need to know.
The majority of Zepbound side effects are gastrointestinal (digestive-related). These are usually most noticeable when you first start the medication or when your dose increases.
These symptoms are typically mild to moderate and often improve as your body adjusts over several weeks.
Zepbound slows how quickly your stomach empties and helps you feel full longer. While this supports weight loss, it can also lead to nausea, bloating, or changes in bowel habits—especially early on.
For most people:
Your prescribing provider will usually start you on a lower dose and gradually increase it. This "dose escalation" helps reduce side effects.
If symptoms are persistent, severe, or worsening, speak with your healthcare provider.
There are practical steps you can take to minimize discomfort.
If side effects interfere with daily life, your provider may adjust your dose or recommend supportive treatments.
Although less common, there are important safety warnings associated with Zepbound.
Zepbound carries an FDA boxed warning about a possible risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on animal studies. It's not known if this risk applies to humans.
Do not use Zepbound if you:
Call your doctor right away if you notice:
These symptoms are rare but require immediate medical attention.
Inflammation of the pancreas (pancreatitis) has been reported with GLP-1–based medications.
Seek urgent medical care if you develop:
Pancreatitis can be serious and requires prompt evaluation.
Rapid weight loss itself can increase the risk of gallstones. Zepbound may also increase the risk of gallbladder disease.
Symptoms include:
Contact your healthcare provider if you experience these symptoms.
Zepbound alone does not usually cause low blood sugar. However, risk increases if you:
Symptoms of low blood sugar include:
Your provider may need to adjust other diabetes medications.
Severe vomiting or diarrhea can lead to dehydration, which may worsen kidney function.
Stay hydrated and contact your doctor if you:
Although rare, serious allergic reactions can occur.
Call emergency services immediately if you experience:
These symptoms can be life-threatening.
You may not be a candidate if you:
If you have a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or kidney problems, discuss risks and benefits carefully with your provider.
Weight management medications can affect appetite, body image, and energy levels. While not common, mood changes should be discussed with your provider.
Sustainable weight loss also includes:
Medication is just one part of a long-term plan.
If you're experiencing unusual symptoms or aren't sure whether your side effects are related to Zepbound, you can use Ubie's free AI-powered symptom checker to help identify what might be causing your discomfort and get personalized guidance on next steps.
Seek urgent or emergency medical care if you experience:
Even if symptoms seem mild but feel unusual for you, it's always appropriate to reach out to your healthcare provider.
Most Zepbound side effects are digestive and improve over time, especially with gradual dose increases. Many people tolerate the medication well and experience meaningful weight loss benefits.
However, serious risks—though uncommon—do exist. Understanding warning signs allows you to act quickly if needed.
Before starting Zepbound:
If you experience anything severe, persistent, or concerning, speak to a doctor immediately—especially for symptoms that could be life-threatening.
Weight management is a medical journey, not a quick fix. With the right supervision and awareness of potential Zepbound side effects, you can make informed decisions about whether this medication is right for you.
(References)
* Wang X, Li J, Sun W, Zuo S, Ding H. Gastrointestinal adverse events with tirzepatide: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024 Jan 5;14:1330962. doi: 10.3389/fendo.2023.1330962. PMID: 38202577.
* Hu J, Wu J, Ma X, Hu J, Sun Z, Gu H, Hu Y, Chen S. Safety and Efficacy of Tirzepatide in Patients with Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Obes Surg. 2024 Jan;34(1):207-217. doi: 10.1007/s11695-023-06899-7. PMID: 37941784.
* Chhabra M, Chhabra K, Jain K, Aggarwal S, Shah H, Shrivastava T, Arora T. Tirzepatide for the treatment of obesity: a review of the SURMOUNT-1 trial. Rev Endocr Metab Disord. 2023 Feb;24(1):163-170. doi: 10.1007/s11154-022-09772-7. PMID: 36725227.
* Lim XW, Chan C, Tey SL. Tirzepatide for Obesity and Weight Management: A Narrative Review. Curr Obes Rep. 2023 Dec;12(4):444-460. doi: 10.1007/s13679-023-00518-8. PMID: 37624108.
* Wang J, Lu W, Hu X, Zheng D, Zhang H, Yu B, Ma Y. Cardiorenal and Metabolic Effects of Tirzepatide for Type 2 Diabetes, Overweight, and Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Obes Surg. 2023 Aug;33(8):2400-2412. doi: 10.1007/s11695-023-06692-7. PMID: 37302484.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.